Evidence-based non-skeletal actions of vitamin D;Evidências das ações não esqueléticas da vitamina D

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 2, 2010, Pages 110-117

  Muszkat, Patricia ^a   Camargo, Marilia Brasilio Rodrigues ^a   Griz, Luiz Henrique Maciel ^b   Lazaretti Castro, Marise ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Calcium; Cancer; Deficiency; Metabolism; Muscle strength; Vitamin D

Indexed keywords

EID: 77952739257     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000200005     Document Type: Review

References (54)

1. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(suppl):491S-9S.
2. Saraiva GL, Cendoroglo MS, Ramos LR, Araújo LM, Vieira JG, Kunii I, et al. Influence of ultraviolet radiation on the production of 25-hydroxyvitamin D in the elderly population in the city of Sao Paulo (23 degrees 34'S), Brazil. Osteoporos Int. 2005;16(12):1649-54.
3. Maeda SS, Kunii IS, Hayashi L, Lazaretti-Castro M. The effect of sun exposure on 25-hydroxyvitamin D concentrations in young healthy subjects living in the city of Sao Paulo, Brazil. Braz J Med Biol Res. 2007;40(12):1653-9. [Epub 2007 Oct 29]
4. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477-501.
5. Saraiva GL, Cendoroglo MS, Ramos LR, Araújo LM, Vieira JG, Maeda SS, et al. Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of Sao Paulo, Brazil. Arq Bras Endocrinol Metabol. 2007;51(3):437-42.
6. Lucas RM, Repacholi MH, McMichael AJ. Is the current public health message on UV exposure correct? Bull World Health Organ. 2006;84:485-91.
7. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol. 2005;289:F8-28.
8. Autier P, Gandini S. Vitamin D supplementation and total mortality. Arch Intern Med. 2007;167(16):1730-7.
9. 3 on breast cells: a mini review. Braz J Med Biol Res. 2002;35(1):1-9.
10. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-76.
11. Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Experiment Dermatol. 2007;16:618-25.
12. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662-87.
13. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005;10(2):94-111.
14. Bishoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson- Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28.
15. Kriebitzsch C, Verlinden L, Eelen G, Tan BK, Van Camp M, Bouillon R, et al. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells - A microarray approach. Anticancer Res. 2009;29(9):3471-83.
16. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. 2009. Epub 2009 Oct 23. [Epub ahead of print]
17. Garlan CF, Gorham ED, Mohr S, Garland F. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19:468-83.
18. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-96.
19. Yin M, Wei S, Wei Q. Vitamin D receptor genetic polymorfisms and prostate cancer risk: a meta-analysis of 36 published studies. In J Clin Exp Med. 2009;2:159-175.
20. 3 metabolism in prostate cancer. J Steroid Biochem Mol Biol. 2004;92(4):317-25. Epub 2004 Dec 19.
21. 3 and the immune system. Mol Cell Endocrinol. 1985;43(2-3):113-22.
22. Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives from mice and man. J Bone Min Res. 2008;23(7): 974-79.
23. Grant WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006;92:65-79.
24. Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr. 2009;154(1):132-4.
25. Bener A, Alsaied A, Al-Ali M, Al-Kubaisi A, Basha B, Abraham A, et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009;46(3):183-9.
26. Ponsonby AL, Pezic A, Ellis J, Morley R, Cameron F, Carlin J, et al. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am J Epidemiol. 2008;168(4):358-65.
27. Mory DB, Rocco ER, Miranda WL, Kasamatsu T, Crispim F, Dib SA. Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function. Hum Immunol. 2009;70(6):447-51.
28. Schuch NJ, Garcia VC, Martini LA. Vitamin D and endocrine diseases. Arq Bras Endocrinol Metab. 2009;53:625-33.
29. 3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267:356-60.
30. 3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89-90(1- 5):121-5.
31. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823-5.
32. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006;29:2244-6.
33. Gedik A, Akalin S. Effects of Vitamin D deficiency and repletion on insulin and glucagons secretion in man. Diabetologia. 1986;29:142-5.
34. 3 on insulin secretion. Diabetes. 1981;30(5):382-6.
35. 3 of insulin receptor expression and responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000;47:383-91.
36. 3, diabetes and ethnicity in the National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813-8.
37. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy Vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57(10):2619-25.
38. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25 hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30:2569-70.
39. Pitas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29:650-6.
40. Pedrosa MAC, Lazaretti-Castro M. Papel da vitamina D na função neuromuscular. Arq Bras Endocrinol Metab. 2005;49:495-502.
41. Demay M. Muscle: a nontraditional 1,25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent vitamin D receptor actions. Endocrinology. 2003;144(12):5135-7.
42. Bouillon R, Bischoff-Ferrari H, Willett. Vitamin D and health: perspective from mice and men. J Bone Min Res. 2008;23(7):974-9.
43. Janssen HCP, Samson MM, Verhaar H. Vitamin D deficiency, muscle function, and fals in elderly people. Am J Clin Nutr. 2002;75:611-5.
44. Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab. 2009;54(4):291-300.
45. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. BMJ. 2009;339:b3692.
46. Sugiura S, Inaguma D, Kitagawa A, Murata M, et al. Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events. Clin Exp Nephrol. 2010;14(1):43-50. [Epub 2009 Oct 31]
47. 3 is a negative endocrine regulator of renin-angiotensin system. J Clin Invest. 2002;110(2):229-38.
48. Brown AJ, Slatopolsky E. Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol Aspects Med. 2008;29(6):433-52. Epub 2008 May 1. Review
49. Murphy PK, Wagner CL. Vitamin D and mood disorders among women: an integrative review. J Midwifery Womens Health. 2008;53(5):440-6.
50. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14(12): 1032-40.
51. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25 hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-7.
52. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65(5):508-12.
53. Gombart A. The vitamin D-antimicrobial pathway and its role in protection against infection. Future Microbiol. 2009;4(9):1151-65.
54. Nnoaham KE, Clarke A. Low serum vitamin D and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37:113-9.